Ayala M - Search Results

1

Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates.

Morera Y, Bequet-Romero M, Ayala M, Velazco JC, Pérez PP, Alba JS, Ancizar J, Rodríguez M, Cosme K, Gavilondo JV. Morera Y, et al. Among authors: ayala m. Vaccine. 2010 Apr 26;28(19):3453-61. doi: 10.1016/j.vaccine.2010.02.069. Epub 2010 Mar 1. Vaccine. 2010. PMID: 20197134

2

Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.

Morera Y, Bequet-Romero M, Ayala M, Lamdán H, Agger EM, Andersen P, Gavilondo JV. Morera Y, et al. Among authors: ayala m. Angiogenesis. 2008;11(4):381-93. doi: 10.1007/s10456-008-9121-5. Epub 2008 Nov 26. Angiogenesis. 2008. PMID: 19034678

3

Antigen dose escalation study of a VEGF-based therapeutic cancer vaccine in non human primates.

Morera Y, Bequet-Romero M, Ayala M, Pérez PP, Castro J, Sánchez J, Alba JS, Ancízar J, Cosme K, Gavilondo JV. Morera Y, et al. Among authors: ayala m. Vaccine. 2012 Jan 5;30(2):368-77. doi: 10.1016/j.vaccine.2011.10.082. Epub 2011 Nov 7. Vaccine. 2012. PMID: 22075086

4

Vaccine CIGB 247 is potentially safe for use as a novel therapeutic vaccine against cancer in Chlorocebus aethiops monkeys.

Castro J, Puente P, Martínez R, Hernández A, Morera Y, Martínez L, Aldana L, Valdés I, Ayala M, Cosme K. Castro J, et al. Among authors: ayala m. Int Immunopharmacol. 2017 Jul;48:55-60. doi: 10.1016/j.intimp.2017.04.023. Epub 2017 May 3. Int Immunopharmacol. 2017. PMID: 28463787

5

Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine.

Morera Y, Sánchez J, Bequet-Romero M, Selman-Housein KH, de la Torre A, Hernández-Bernal F, Martín Y, Garabito A, Piñero J, Bermúdez C, de la Torre J, Ayala M, Gavilondo JV. Morera Y, et al. Among authors: ayala m. Vaccine. 2017 Jun 16;35(28):3582-3590. doi: 10.1016/j.vaccine.2017.05.020. Epub 2017 May 20. Vaccine. 2017. PMID: 28536029 Clinical Trial.

6

An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification.

Pujol M, Ramírez NI, Ayala M, Gavilondo JV, Valdés R, Rodríguez M, Brito J, Padilla S, Gómez L, Reyes B, Peral R, Pérez M, Marcelo JL, Milá L, Sánchez RF, Páez R, Cremata JA, Enríquez G, Mendoza O, Ortega M, Borroto C. Pujol M, et al. Among authors: ayala m. Vaccine. 2005 Mar 7;23(15):1833-7. doi: 10.1016/j.vaccine.2004.11.023. Vaccine. 2005. PMID: 15734051 Review.

7

Biologically active vascular endothelial growth factor as a bacterial recombinant glutathione S-transferase fusion protein.

Morera Y, Lamdan H, Bequet M, Ayala M, Rojas G, Muñoz Y, Gavilondo JV. Morera Y, et al. Among authors: ayala m. Biotechnol Appl Biochem. 2006 Apr;44(Pt 1):45-53. doi: 10.1042/BA20050169. Biotechnol Appl Biochem. 2006. PMID: 16401185

8

Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.

Bequet-Romero M, Ayala M, Acevedo BE, Rodríguez EG, Ocejo OL, Torrens I, Gavilondo JV. Bequet-Romero M, et al. Among authors: ayala m. Angiogenesis. 2007;10(1):23-34. doi: 10.1007/s10456-006-9062-9. Epub 2007 Feb 2. Angiogenesis. 2007. PMID: 17273909

9

Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope disturbing strategy.

Lamdan H, Ayala M, Rojas G, Munoz Y, Morera Y, Guirola O, Chinea G, Gavilondo JV. Lamdan H, et al. Among authors: ayala m. J Biotechnol. 2011 Jan 20;151(2):166-74. doi: 10.1016/j.jbiotec.2010.12.007. Epub 2010 Dec 15. J Biotechnol. 2011. PMID: 21167224

10

Vaccination with a mutated variant of human Vascular Endothelial Growth Factor (VEGF) blocks VEGF-induced retinal neovascularization in a rabbit experimental model.

Morera Y, González R, Lamdan H, Pérez L, González Y, Agüero J, Castro J, Romero JC, Etchegoyen AY, Ayala M, Gavilondo JV. Morera Y, et al. Among authors: ayala m. Exp Eye Res. 2014 May;122:102-9. doi: 10.1016/j.exer.2014.03.006. Epub 2014 Mar 25. Exp Eye Res. 2014. PMID: 24675387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page